FDA Inspection 1239864 — Hisun Pharmaceuticals USA, Inc.
The FDA completed an inspection of Hisun Pharmaceuticals USA, Inc. on May 9, 2024 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bridgewater, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)